Literature DB >> 19940753

Pagetoid reticulosis after radiotherapy of primary cutaneous anaplastic large-cell lymphoma.

Stephen E Mercer1, Claudia I Vidal, Sarah E Grummer, James A Strauchen, Marsha L Gordon, Miriam B Birge.   

Abstract

We describe a 60-year-old man with a history of primary cutaneous anaplastic large cell lymphoma on the chest, who presented with a new scaly red plaque on the same site 11 years after radiation therapy. Histological examination revealed a dense epidermotropic infiltrate of atypical mononuclear cells consistent with pagetoid reticulosis. Immunohistochemistry revealed the infiltrate to be CD4, CD8, and CD30. Remarkably, all the atypical cells were strongly CD30, and furthermore, the CD30 cells were found exclusively in the epidermis. In the initial cutaneous anaplastic large cell lymphoma lesion, the CD4, CD8, and focally CD30 atypical cells were well confined within the dermis with no epidermal component. To our knowledge, the present case seems to be the first description of pagetoid reticulosis presenting at the site of a previously treated dermal anaplastic large cell lymphoma. This case also represents an extreme presentation of epidermotropism and CD30 expression in pagetoid reticulosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19940753     DOI: 10.1097/DAD.0b013e3181b15a8a

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

1.  A case of primary cutaneous anaplastic large cell lymphoma with prominent epidermotropism.

Authors:  Tomomitsu Miyagaki; Makoto Sugaya; Akie Miyamoto; Kunihiko Tamaki; Satoshi Ota; Shinichi Sato
Journal:  Int J Hematol       Date:  2012-03-27       Impact factor: 2.490

2.  [Pagetoid reticulosis in a patient with mycosis fungoides. Successful therapy with localized electron beam irradiation].

Authors:  C Mühlhoff; B Krenkel; A Rübben; M Megahed
Journal:  Hautarzt       Date:  2010-05       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.